7,8-Dihydroxycoumarin inhibits A549 human lung adenocarcinoma cell proliferation by inducing apoptosis via suppression of Akt/NF-κB signaling

Wang,Yue; Li,Chang-Feng; Pan,Li-Ming; Gao,Zhong-Li

doi:10.3892/etm.2013.1054

7,8-Dihydroxycoumarin inhibits A549 human lung adenocarcinoma cell proliferation by inducing apoptosis via suppression of Akt/NF-κB signaling

Authors:
- Yue Wang
- Chang-Feng Li
- Li-Ming Pan
- Zhong-Li Gao
View Affiliations

Affiliations: Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 133033, P.R. China, Department of Endoscopy, China-Japan Union Hospital of Jilin University, Changchun, Jilin 133033, P.R. China, Department of Pediatrics, The First Bethune Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Published online on: April 9, 2013 https://doi.org/10.3892/etm.2013.1054
Pages: 1770-1774

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The Akt/NF-κB pathways are involved in numerous anti-apoptotic and drug-resistance events that occur in non‑small cell lung cancer (NSCLC). In the present study, the role of 7,8-dihydroxycoumarin in the regulation of the anti‑apoptotic Akt and NF-κBp65 signaling pathways was explored. A549 human lung adenocarcinoma cells were exposed to 7,8-dihydroxycoumarin with a final concentration of 25, 50 and 100 µmol/l for 48 h. Quantitative polymerase chain reaction (PCR) and western blotting were performed to detect mRNA and protein expression, respectively. The MTT assay was performed to detect cell proliferation. The results demonstrated that anti‑apoptotic phospho-Akt1 (pAkt1), phospho-IκBα (pIκBα), NF-κBp65 and Bcl-2 were inhibited and pro-apoptotic caspase-3 was upregulated in a concentration-dependent manner. At a concentration of 100 µmol/l, the anti-apoptotic NF-κBp65 and Bcl-2 mRNA expression levels decreased 0.12 (5.82/48.5, treated/control)-fold and 0.17 (6.7/39.4, treated/control)-fold, respectively. The pro-apoptotic caspase-3 mRNA was upregulated 4.43 (39.4/8.9, treated/control)‑fold. The anti‑apoptotic pAkt1, pIκBα, NF-κBp65 and Bcl-2 proteins were downregulated, with blot grayscale values of 7.3 (vs. 52.4 control), 4.3 (vs. 42.2 control), 5.08 (vs. 44.5 control) and 5.92 (vs. 38.5 control), respectively. The pro-apoptotic caspase-3 was upregulated to a blot grayscale value of 27.8 (vs. 5.8 control). The proliferative activity of A549 cells was reduced significantly compared with that of the control cells (83.7, 27.2 and 9.5 vs. 100%, respectively; P<0.05 for each). 7,8-Dihydroxycoumarin plays an important role in the induction of apoptosis via suppression of Akt/NF-κB signaling in A549 human lung adenocarcinoma cells in a concentration-dependent manner. 7,8-Dihydroxycoumarin may be a candidate naturally-occurring drug for the treatment and prevention of lung adenocarcinoma.

View Figures

View References

1.	Kontogiorgis C, Detsi A and Hadjipavlou-Litina D: Coumarin-based drugs: a patent review (2008 - present). Expert Opin Ther Pat. 22:437–454. 2012. View Article : Google Scholar : PubMed/NCBI
2.	Anand P, Singh B and Singh N: A review on coumarins as acetylcholinesterase inhibitors for Alzheimer’s disease. Bioorg Med Chem. 20:1175–1180. 2012.
3.	Chakraborty AK, Funasaka Y, Pawelek JM, Nagahama M, Ito A and Ichihashi M: Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J Invest Dermatol. 112:853–860. 1999. View Article : Google Scholar
4.	Yang EB, Zhao YN, Zhang K and Mack P: Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor. Biochem Biophys Res Commun. 260:682–685. 1999. View Article : Google Scholar : PubMed/NCBI
5.	Finn GJ, Creaven BS and Egan DA: Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase. Biochem Pharmacol. 67:1779–1788. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Finn GJ, Kenealy E, Creaven BS and Egan DA: In vitro cytotoxic potential and mechanism of action of selected coumarins using human renal cell lines. Cancer Lett. 183:61–68. 2002. View Article : Google Scholar : PubMed/NCBI
7.	Riveiro ME, Moglioni A, Vazquez R, Gomez N, Facorro G, Piehl L, de Celis ER, Shayo C and Davio C: Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells. Bioorg Med Chem. 16:2665–2675. 2008. View Article : Google Scholar : PubMed/NCBI
8.	Elinos-Báez CM, León F and Santos E: Effects of coumarin and 7OH-coumarin on bcl-2 and Bax expression in two human lung cancer cell lines in vitro. Cell Biol Int. 29:703–708. 2005.PubMed/NCBI
9.	Chuang JY, Huang YF, Lu HF, Ho HC, Yang JS, Li TM, Chang NW and Chung JG: Coumarin induces cell cycle arrest and apoptosis in human cervical cancer HeLa cells through a mitochondria- and caspase-3 dependent mechanism and NF-kappaB down-regulation. In Vivo. 21:1003–1009. 2007.PubMed/NCBI
10.	Saidu NE, Valente S, Bana E, Kirsch G, Bagrel D and Montenarh M: Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells. Bioorg Med Chem. 20:1584–1593. 2012. View Article : Google Scholar : PubMed/NCBI
11.	Bronikowska J, Szliszka E, Jaworska D, Czuba ZP and Krol W: The coumarin psoralidin enhances anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Molecules. 17:6449–6464. 2012. View Article : Google Scholar
12.	Rasul A, Khan M, Yu B, Ma T and Yang H: Xanthoxyletin, a coumarin induces S phase arrest and apoptosis in human gastric adenocarcinoma SGC-7901 cells. Asian Pac J Cancer Prev. 12:1219–1223. 2011.PubMed/NCBI
13.	Bhattacharyya SS, Paul S, Dutta S, Boujedaini N and Khuda-Bukhsh AR: Anti-oncogenic potentials of a plant coumarin (7-hydroxy-6-methoxy coumarin) against 7,12-dimethylbenz [a] anthracene-induced skin papilloma in mice: the possible role of several key signal proteins. Zhong Xi Yi Jie He Xue Bao. 8:645–654. 2010.PubMed/NCBI
14.	Singh RK, Lange TS, Kim KK and Brard L: A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Invest New Drugs. 29:63–72. 2011. View Article : Google Scholar : PubMed/NCBI
15.	Bhattacharyya SS, Paul S, Mandal SK, Banerjee A, Boujedaini N and Khuda-Bukhsh AR: A synthetic coumarin (4-methyl-7 hydroxy coumarin) has anti-cancer potentials against DMBA-induced skin cancer in mice. Eur J Pharmacol. 614:128–136. 2009. View Article : Google Scholar : PubMed/NCBI
16.	Thati B, Noble A, Creaven BS, Walsh M, McCann M, Devereux M, Kavanagh K and Egan DA: Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells. Eur J Pharmacol. 602:203–214. 2009. View Article : Google Scholar
17.	Hsu YL, Kuo PL and Lin CC: Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by 7,8-dihydroxycoumarin in human non-small cell lung cancer A549 cells. Life Sci. 75:2303–2316. 2004. View Article : Google Scholar : PubMed/NCBI
18.	Li Y, Xing D, Chen Q and Chen WR: Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using 7,8-dihydroxycoumarin. Int J Cancer. 127:462–473. 2010.PubMed/NCBI
19.	Jang BC: The fruit juice of Morinda citrifolia (noni) down-regulates HIF-1α protein expression through inhibition of PKB, ERK-1/2, JNK-1 and S6 in manganese-stimulated A549 human lung cancer cells. Int J Mol Med. 29:499–504. 2012.
20.	Barkett M and Gilmore TD: Control of apoptosis by Rel/NF-κB transcription factors. Oncogene. 18:6910–6924. 1999.
21.	Tang G, Yang J, Minemoto Y and Lin A: Blocking caspase-3 mediated proteolysis of IKKβ suppresses TNF-α-induced apoptosis. Mol Cell. 8:1005–1016. 2001.PubMed/NCBI
22.	Ravi R, Mookerjee B, van Hensbergen Y, Bedi GC, Giordano A, El-Deiry WS, Fuchs EJ and Bedi A: p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res. 58:4531–4536. 1998.PubMed/NCBI